Skip to content

This website is intended for UK healthcare professionals only

This is a promotional website developed by AstraZeneca

The prescribing information can be found at the bottom of the page

bars

Tagrisso Case Studies

View cases by PROFILE (i.e. early stage, first line, second line) or by FORMAT
(i.e. podcasts, videos, interactive module) by selecting from the dropdown

chevron down


Tagrisso cardiotoxicity – an interesting case

Dr Arjun K Ghosh, Consultant Cardiologist, Barts Heart Centre and University College London Hospital

Tagrisso cardiotoxicity overview

Dr Arjun K Ghosh, Consultant Cardiologist, Barts Heart Centre and University College London Hospital

Stage IIB patient case study of adjuvant osimertinib

Dr Jason Chow, Consultant Medical Oncologist, St George’s Hospital

Severe reactions and warning signs

Dr David Rutkowski, Dermatology registrar and MRC clinical pharmacology fellow, NHS and University of Manchester

Introduction to EGFRi Skin toxicity

Dr David Rutkowski, Dermatology registrar and MRC clinical pharmacology fellow, NHS and University of Manchester

Management of skin toxicity

Dr David Rutkowski, Dermatology registrar and MRC clinical pharmacology fellow, NHS and University of Manchester

Tagrisso Case Study: First-Line EGFRm+ NSCLC – 45M

Dr Shobhit Baijal, Consultant Medical Oncologist, University Hospitals Birmingham

Tagrisso Case Study: First-line EGFRm+ NSCLC – 81F

Dr Ashley Cox, Consultant Clinical Oncologist Royal United Hospital Bath

Tagrisso Case Study: Second line EGFRm+ NSCLC – 63F

Dr David Woolf, Consultant Clinical Oncologist, Christie NHS Foundation Trust

Working with your patients to enhance their treatment pathway

Dr Gary Doherty, Consultant Medical Oncologist, Cambridge University Hospitals NHS Foundation Trust
Ms Rachel Powell, Advanced Clinical Practitioner, University of Birmingham Hospitals NHS Foundation Trust

Tagrisso Case Study: First line EGFRm+ NSCLC – 84F

Dr Tom Newsom-Davis, Consultant Medical Oncologist, Chelsea and Westminster NHS Foundation Trust

Tagrisso Case Study: First line EGFRm+ NSCLC – 71F

Dr Tom Newsom-Davis, Consultant Medical Oncologist, Chelsea and Westminster NHS Foundation Trust

Tagrisso Case Study: First line EGFRm+ NSCLC – 76F

Dr David Woolf, Consultant Clinical Oncologist, Christie NHS Foundation Trust

Adjuvant setting case studies

Dr Marcus Remer, Consultant Medical Oncologist, Hampshire Hospitals NHS Foundation Trust